Crossmark

Insulin Degludec, a Novel Ultra-Long-Acting Basal Insulin versus Insulin Glargine for the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis

Crossref DOI link: https://doi.org/10.1007/s13300-019-0624-4

Published Online: 2019-04-24

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Wenchuan

Tao, Jinxin

Zhou, Xiaodong

Chen, Hongxia
Funding

Funding for this research was provided by:

Natural Science Foundation of China (No. 81560395)

The Funder is not listed in the FundRef Registry. Click 'OK' to proceed with this Funding Source or click 'Cancel' to search again (No. 2007GQY1167)
License Information

Text and Data Mining valid from 2019-04-24

Version of Record valid from 2019-04-24
More Information

Article History

Received: 21 March 2019

First Online: 24 April 2019

Document is current

Any future updates will be listed below